<?xml version="1.0" encoding="UTF-8"?>
<records>
<record>
<language>eng</language>
<publisher>Science and Education Publishing</publisher>
<journalTitle>American Journal of Epidemiology and Infectious Disease</journalTitle>
<publicationDate>2013-08-15</publicationDate>
<volume>1</volume>
<issue>1</issue>
<startPage>24</startPage>
<endPage>26</endPage>
<doi>10.12691/ajeid-1-3-2</doi>
<publisherRecordId>AJEID2013132</publisherRecordId>
<documentType>article</documentType>
<title language="eng">Epidemiology of Vancomycin Resistant <i>S</i><i>taphyloccus</i><i> A</i><i>ureus</i> among Clinical Isolates in a Tertiary Hospital in Abakaliki, Nigeria</title>
<authors>
<author>
<name>Alo Moses</name>
<affiliationId>1</affiliationId>
</author>
<author>
<name>Ugah Uchenna</name>
<email>ugahuchennaiyioku@gmail.com</email>
<affiliationId>2</affiliationId>
</author>
<author>
<name>Okoro Nworie</name>
<affiliationId>2</affiliationId>
</author>

</authors>
<affiliationsList>
<affiliationName affiliationId="1">Department of Biological Science, Federal University Ndufu-Alike Ikwo, Ebonyi State</affiliationName>
<affiliationName affiliationId="2">Department of Medical Laboratory Science, Ebonyi State University Abakaliki, Ebonyi State</affiliationName>

</affiliationsList>
<abstract language="eng"><i>Staphylococcus aureus </i>is a successful pathogen due to a combination of numerous bacteria immune-evasive strategies. The increased incidence of MRSA has led to more frequent use of vancomycin, the drug commonly relied upon as last resorts for treating MRSA infections. As a consequence, selective pressure was established that led to the emergence of strains of <i>S. aureus </i>and other species of <i>Staphylococci</i> with decreased susceptibility to vancomycin and other glycopeptides. The aim of our study was to determine the prevalence of vancomycin resistant <i>S. aureus </i>among clinical isolates in a tertiary health care facility in Abakaliki metropolis, the capital of Ebonyi State, South Eastern Nigeria. The susceptibility of S. aureus strains to vancomycin was determined by Kirby-Bauer disk diffusion technique as well as by tube dilution method. Among the 355 <i>S. aureus</i> isolates tested, 272 (76.6%) isolates were susceptible (zone diameter ≥ 15mm, MIC 0.5-2μg/ml) 64 (18.0%) isolates were intermediate (zone diameter≤ 14mm, MIC 4-8μg/ml) while 19 (5.4%) isolates were resistant (zone diameter≤14mm, MIC ≥ 16μg/ml). When subjected to statistical analysis, this prevalence rate was statistically non-significant (p &lt; 0.05). But, nevertheless, clinically relevant considering the overall implication in the transfer of resistant gene.</abstract>
<fullTextUrl format="pdf">http://pubs.sciepub.com/ajeid/1/3/2/ajeid-1-3-2.pdf</fullTextUrl>
<keywords language="eng"><keyword>vancomycin</keyword>
<keyword>resistance</keyword>
<keyword>Staphylococcus aureus</keyword>
<keyword>Abakaliki</keyword>
</keywords>
</record>
</records>
